| |
| |
|
| Insider
Information: |
Bullock Lawrence E |
| Relationship: |
Chief Financial Officer |
| City: |
Franklin |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
10,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,936 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
10,000 |
|
|
| Total
Value |
$3,936 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomimetic Therapeutics, Inc. |
BMTI |
Chief Financial Officer |
2013-03-01 |
0 |
2013-03-01 |
0 |
Premium* |
|
|
Applied Genetic Technologies Corp |
AGTC |
Chief Financial Officer |
2016-09-19 |
10,000 |
2016-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGTC |
Applied Genetic Technolog... |
Chief Financial Officer |
• – – |
2016-09-19 |
4 |
B |
$8.75 |
$87,500 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2013-03-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(21,000) |
0 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(89,151) |
0 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2012-03-20 |
4 |
B |
$2.20 |
$38,874 |
D/D |
17,670 |
78,723 |
2.74 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2012-03-19 |
4 |
B |
$2.20 |
$5,126 |
D/D |
2,330 |
61,053 |
2.74 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2011-10-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
16,000 |
28,000 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2011-10-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
16,000 |
58,723 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2010-12-03 |
4 |
OE |
$3.63 |
$136,125 |
D/D |
37,500 |
65,620 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2010-01-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,000 |
12,000 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2010-01-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
26,158 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2009-04-01 |
4 |
B |
$6.72 |
$40,824 |
D/D |
6,000 |
28,668 |
2.74 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2008-03-28 |
4 |
B |
$9.00 |
$90,000 |
D/D |
10,000 |
22,135 |
2.74 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2008-02-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,000 |
4,000 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2008-02-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
22,668 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2007-12-31 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,000 |
2,000 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2007-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
12,135 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Chief Financial Officer |
• – – |
2006-05-12 |
4 |
B |
$8.00 |
$80,000 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
